Tenecteplase versus alteplase in bridging therapy in patients with large vessel occlusion stroke: a meta-analysis
BackgroundCurrently, for patients with large-vessel occlusion (LVO) strokes, the standard treatment approach involves using alteplase (ALT) as a bridge to endovascular mechanical thrombectomy (MT). Tenecteplase (TNK) is a novel fibrinolytic agent. Our research is focused on evaluating and comparing...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2025-11-01
|
| סדרה: | Frontiers in Neurology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1661357/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
